The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of salvage radiotherapy in relapsed/refractory large B-cell lymphoma patients following CAR T-cell therapy failure.
 
Hazim Ababneh
No Relationships to Disclose
 
Andrea Ng
No Relationships to Disclose
 
Matthew Frigault
Stock and Other Ownership Interests - Immunofree
Consulting or Advisory Role - Bristol-Myers Squibb/Juno; Cytoagents; Gilead Sciences; Novartis
Research Funding - SOBI
Patents, Royalties, Other Intellectual Property - Own IP related to chimeric antigen receptors and T cell manufacturing
 
Caron Jacobson
Honoraria - Abbvie; ADC Therapeutics; Aleta Biotherapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Caribou Biosciences; Janssen; Kite/Gilead; Kyverna Therapeutics; Miltenyi Biomedicine; Novartis; Sana; Synthekine
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Aleta Biotherapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Janssen; Kite/Gilead; Kyverna Therapeutics; Miltenyi Biomedicine; Novartis; Sana; Synthekine
Research Funding - Kite, a Gilead company
 
Chirayu Patel
No Relationships to Disclose